The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utility of plasma ctDNA sequencing in metastatic urothelial carcinoma.
 
Clara Helal
No Relationships to Disclose
 
Cedric Pobel
No Relationships to Disclose
 
Arnaud Bayle
Consulting or Advisory Role - Sanofi
 
Damien Vasseur
No Relationships to Disclose
 
Claudio Nicotra
No Relationships to Disclose
 
Felix Blanc-Durand
Honoraria - Cureety
Consulting or Advisory Role - AstraZeneca/Merck (Inst); Eisai/MSD; GlaxoSmithKline (Inst)
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; GlaxoSmithKline
 
Natacha Naoun
Travel, Accommodations, Expenses - Merck
 
Alice Bernard-Tessier
Honoraria - Astellas Pharma; Bayer
Consulting or Advisory Role - Novartis; Orion Clinical
Travel, Accommodations, Expenses - Bayer; Orion Clinical
 
Anna Patrikidou
Consulting or Advisory Role - Basilea
Travel, Accommodations, Expenses - Amgen; Janssen
 
Emeline Colomba
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Merck
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Pfizer
 
Ronan Flippot
Honoraria - Astellas Pharma; Bristol-Myers Squibb; IPSEN; MSD Oncology; Pfizer
Consulting or Advisory Role - Ipsen; Janssen Oncology
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; Merck/Pfizer; Merck/Pfizer
 
Alina Fuerea
No Relationships to Disclose
 
Nathalie Auger
No Relationships to Disclose
 
Maud Ngocamus
No Relationships to Disclose
 
Benjamin Besse
Research Funding - Abbvie (Inst); Amgen (Inst); Aptitude Health (Inst); AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Ellipses Pharma (Inst); Genmab (Inst); Genzyme (Inst); Genzyme (Inst); Hedera Dx (Inst); Inivata (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); PharmaMar (Inst); Roche/Genentech (Inst); Sanofi (Inst); socar (Inst); Taiho Pharmaceutical (Inst); Turning Point Therapeutics (Inst)
 
Ludovic Lacroix
No Relationships to Disclose
 
Etienne Rouleau
Honoraria - AstraZeneca (Inst); BMS (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); MSD Oncology (Inst); MSD Oncology (Inst); Roche (Inst)
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS
 
Santiago Ponce Aix
No Relationships to Disclose
 
Antoine Italiano
No Relationships to Disclose
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Immunomedics; Janssen; Janssen (Inst); Loxo/Lilly; MSD Oncology; MSD Oncology (Inst); Pfizer/EMD Serono; Roche; Seagen; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Basilea (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen